Takaya, H.; Namisaki, T.; Takeda, S.; Kaji, K.; Ogawa, H.; Ishida, K.; Tsuji, Y.; Takagi, H.; Ozutsumi, T.; Fujinaga, Y.;
et al. The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. J. Clin. Med. 2021, 10, 4838.
https://doi.org/10.3390/jcm10214838
AMA Style
Takaya H, Namisaki T, Takeda S, Kaji K, Ogawa H, Ishida K, Tsuji Y, Takagi H, Ozutsumi T, Fujinaga Y,
et al. The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. Journal of Clinical Medicine. 2021; 10(21):4838.
https://doi.org/10.3390/jcm10214838
Chicago/Turabian Style
Takaya, Hiroaki, Tadashi Namisaki, Soichi Takeda, Kosuke Kaji, Hiroyuki Ogawa, Koji Ishida, Yuki Tsuji, Hirotetsu Takagi, Takahiro Ozutsumi, Yukihisa Fujinaga,
and et al. 2021. "The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria" Journal of Clinical Medicine 10, no. 21: 4838.
https://doi.org/10.3390/jcm10214838
APA Style
Takaya, H., Namisaki, T., Takeda, S., Kaji, K., Ogawa, H., Ishida, K., Tsuji, Y., Takagi, H., Ozutsumi, T., Fujinaga, Y., Furukawa, M., Kitagawa, K., Nishimura, N., Sawada, Y., Shimozato, N., Kawaratani, H., Moriya, K., Akahane, T., Mitoro, A.,
& Yoshiji, H.
(2021). The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. Journal of Clinical Medicine, 10(21), 4838.
https://doi.org/10.3390/jcm10214838
